Poolbeg Pharma PLC (POLB.L) Stock

POLB.L logo

Poolbeg Pharma PLC

POLB.LUnited Kingdom
Healthcare

Company profile

Poolbeg Pharma reports about 15 full-time employees.

Figures from company filings; latest fiscal year ended December 31, 2024.

About Poolbeg Pharma PLC

Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome; and phase 2 for the treatment of influenza. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; and AI program, a novel drug discovery therapies for the treatment of influenza and respiratory syncytial viruses. Poolbeg Pharma plc was incorporated in 2021 and is based in London, United Kingdom.

Largest shareholders

  • Cathal Friel5.378 %5.38%
  • Hargreaves Lansdown Fund Managers Ltd.3.48%
  • Schroder Investment Management Ltd.3.27%
  • IG Markets Ltd.2.90%
  • HSBC Bank Plc (Market-Maker)1.42%

Share of the company, as of September 25, 2026

Leadership

  • Jeremy Skillington Ph.D. — CEO & Director, 54
  • Cathal Martin Friel — Executive Chairman of The Board, 61
  • Ian O'Connell — CFO & Director, 38
  • Carol Dalton — Vice President of Investor Relations & Public Relations
  • Liam Tremble — Principal Scientist

What companies are similar to Poolbeg Pharma?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include International Biotechnology Ord (IBT.L), Beximco Pharmaceuticals Limited (BXP.L), Venture Life Group plc (VLG.L), Hellenic Dynamics Plc (HELD.L).

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Employees15
Founded2021
IPO DateJul 19, 2021
IPO StatusPublic
HeadquartersLondon, United Kingdom
FoundersCathal Friel
ExchangeLSE
TimezoneEurope/London (GMT)

Contact & Links

Address
The Clubhouse Holborn, London, EC4A 3AG
Phone
44 20 7183 1499
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Poolbeg Pharma PLC (POLB.L)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/POLB.L

LinkedInLinkedInXXYouTubeYouTube